Telenutrition startup Nourish raises $70M

Ngai Yeung

Health Tech Reporter

Telenutrition platform Nourish has raised $70 million and reached profitability a little more than a year after its last raise as food medicine startups get …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Telenutrition startup Nourish raises $70M

Ngai Yeung

Health Tech Reporter

Sign up to read this article for free.

Early bits of in vivo CAR-T human data emerge from biotech trials in China

Recursion cuts nearly half of its pipeline, including its most advanced program

J&J's eye disease gene therapy bota-vec fails in Phase 3 trial

Bristol Myers to lay off over 500 workers in New Jersey

Unity lays off 'all' workers; Novo to get FDA decision on oral Wegovy this year

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges

Te­lenu­tri­tion start­up Nour­ish rais­es $70M

Ngai Yeung

Health Tech Reporter

Sign up to read this article for free.

Ear­ly bits of in vi­vo CAR-T hu­man da­ta emerge from biotech tri­als in Chi­na

Re­cur­sion cuts near­ly half of its pipeline, in­clud­ing its most ad­vanced pro­gram

J&J's eye dis­ease gene ther­a­py bo­ta-vec fails in Phase 3 tri­al

Bris­tol My­ers to lay off over 500 work­ers in New Jer­sey

Uni­ty lays off 'al­l' work­ers; No­vo to get FDA de­ci­sion on oral We­govy this year

In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges

Telenutrition startup Nourish raises $70M

Early bits of in vivo CAR-T human data emerge from biotech trials in China

Recursion cuts nearly half of its pipeline, including its most advanced program

J&J's eye disease gene therapy bota-vec fails in Phase 3 trial

Bristol Myers to lay off over 500 workers in New Jersey

Unity lays off 'all' workers; Novo to get FDA decision on oral Wegovy this year

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges